Skip to main content
Erschienen in: European Radiology 6/2016

22.09.2015 | Head and Neck

Combination of diffusion tensor imaging and conventional MRI correlates with isocitrate dehydrogenase 1/2 mutations but not 1p/19q genotyping in oligodendroglial tumours

verfasst von: Ji Xiong, Wenli Tan, Jianbo Wen, Jiawei Pan, Yin Wang, Jun Zhang, Daoying Geng

Erschienen in: European Radiology | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To explore the correlations of conventional MRI (cMRI) and diffusion tensor imaging (DTI) values with the 1p/19 codeletion and IDH mutations in oligodendroglial tumours (OTs).

Methods

Eighty-four patients with OTs who underwent cMRI and DTI were retrospectively reviewed. The maximal fractional anisotropy and minimal apparent diffusion coefficient (ADC) were measured and compared using the Mann-Whitney U test. Receiver operating characteristic curves, logistic regression analysis and four-table statistics analysis were performed to predict genotypings.

Results

OTs with 1p/19q codeletion or IDH mutations were prone to locate in frontal (P = 0.106 and 0.005, respectively) and insular lobes and were associated with absent or blurry contrast enhancement (P = 0.040 and 0.013, respectively). DTI values showed significant differences between OTs with and without IDH mutations (P < 0.05) but not in OTs with and without 1p/19q loss. The Ki-67 index significantly correlated with IDH mutations (P = 0.002) but not with 1p/19q codeletion. A combination of DTI and cMRI for the identification of IDH mutations resulted in sensitivity, specificity, positive and negative predictive values of 92.2 %, 75.8 %, 93.8 % and 71.1 %, respectively.

Conclusions

Combination of DTI and cMRI correlates with isocitrate dehydrogenase 1/2 mutations but not 1p/19q genotyping in OTs.

Key Points

OTs with 1p/19q codeletion were associated with absent or blurry contrast enhancement
OTs with IDH mutations were also associated with absent or blurry contrast enhancement
OTs with IDH mutations were prone to locate in frontal and insular lobes
DTI values can provide a non-invasive method for assessing the IDH status of OTs
A combination of DTI and cMRI correlates with isocitrate dehydrogenase 1/2 mutations
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Bromberg JE, van den Bent MJ (2009) Oligodendrogliomas: molecular biology and treatment. Oncologist 14:155–163CrossRefPubMed Bromberg JE, van den Bent MJ (2009) Oligodendrogliomas: molecular biology and treatment. Oncologist 14:155–163CrossRefPubMed
2.
Zurück zum Zitat Reifenberger G, Kros JM, Louis DN, Collins VP (2007) Oligodendroglioma and Anaplastic oligodendroglioma. In: Louis DN, Ohgaki H, Wiestler OD (eds) WHO Classification of Tumors of the Central Nervous System. IARC, Lyon, pp 54–62 Reifenberger G, Kros JM, Louis DN, Collins VP (2007) Oligodendroglioma and Anaplastic oligodendroglioma. In: Louis DN, Ohgaki H, Wiestler OD (eds) WHO Classification of Tumors of the Central Nervous System. IARC, Lyon, pp 54–62
3.
Zurück zum Zitat Jaeckle KA, Ballman KV, Rao RD, Jenkins RB, Buckner JC (2006) Current strategies in treatment of oligodendroglioma: evolution of molecular signatures of response. J Clin Oncol 24:1246–1252CrossRefPubMed Jaeckle KA, Ballman KV, Rao RD, Jenkins RB, Buckner JC (2006) Current strategies in treatment of oligodendroglioma: evolution of molecular signatures of response. J Clin Oncol 24:1246–1252CrossRefPubMed
4.
Zurück zum Zitat van den Bent MJ, Brandes AA et al (2013) Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951. J Clin Oncol 31:344–350CrossRefPubMed van den Bent MJ, Brandes AA et al (2013) Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951. J Clin Oncol 31:344–350CrossRefPubMed
5.
Zurück zum Zitat Cairncross G, Wang M, Shaw E et al (2013) Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. J Clin Oncol 31:337–343CrossRefPubMedPubMedCentral Cairncross G, Wang M, Shaw E et al (2013) Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. J Clin Oncol 31:337–343CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Watanabe T, Nobusawa S, Kleihues P, Ohgaki H (2009) IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am J Pathol 174:1149–1153CrossRefPubMedPubMedCentral Watanabe T, Nobusawa S, Kleihues P, Ohgaki H (2009) IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am J Pathol 174:1149–1153CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Sanson M, Marie Y, Paris S et al (2009) Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. J Clin Oncol 27:4150–4154CrossRefPubMed Sanson M, Marie Y, Paris S et al (2009) Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. J Clin Oncol 27:4150–4154CrossRefPubMed
9.
Zurück zum Zitat Frenel JC, Leux C, Loussouarn D et al (2013) Combining two biomarkers, IDH mutationss and 1p/19q codeletion, to stratify anaplastic oligodendroglioma in three groups: a single-center experience. J Neurooncol 114:85–91CrossRefPubMed Frenel JC, Leux C, Loussouarn D et al (2013) Combining two biomarkers, IDH mutationss and 1p/19q codeletion, to stratify anaplastic oligodendroglioma in three groups: a single-center experience. J Neurooncol 114:85–91CrossRefPubMed
10.
Zurück zum Zitat Jenkinson MD, Smith TS, Brodbelt AR et al (2007) Apparent diffusion coefficients in oligodendroglial tumors characterized by genotype. J Magn Reson Imaging 26:1405–1412CrossRefPubMed Jenkinson MD, Smith TS, Brodbelt AR et al (2007) Apparent diffusion coefficients in oligodendroglial tumors characterized by genotype. J Magn Reson Imaging 26:1405–1412CrossRefPubMed
11.
Zurück zum Zitat Fellah S, Caudal D, De Paula AM et al (2013) Multimodal MR Imaging (Diffusion, Perfusion, and Spectroscopy): Is It Possible to Distinguish Oligodendroglial Tumor Grade and 1p/19q Codeletion in the Pretherapeutic Diagnosis? AJNR Am J Neuroradiol 34:1326–1333CrossRefPubMed Fellah S, Caudal D, De Paula AM et al (2013) Multimodal MR Imaging (Diffusion, Perfusion, and Spectroscopy): Is It Possible to Distinguish Oligodendroglial Tumor Grade and 1p/19q Codeletion in the Pretherapeutic Diagnosis? AJNR Am J Neuroradiol 34:1326–1333CrossRefPubMed
12.
Zurück zum Zitat Jenkinson MD, Smith TS, Joyce KA et al (2006) Cerebral blood volume, genotype and chemosensitivity in oligodendroglial tumors. Neuroradiology 48:703–713CrossRefPubMedPubMedCentral Jenkinson MD, Smith TS, Joyce KA et al (2006) Cerebral blood volume, genotype and chemosensitivity in oligodendroglial tumors. Neuroradiology 48:703–713CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Tan WL, Huang WY, Yin B, Xiong J, Wu JS, Geng DY (2014) Can diffusion tensor imaging noninvasively detect IDH1 gene mutations in astrogliomas? A retrospective study of 112 cases. AJNR Am J Neuroradiol 35:920–927CrossRefPubMed Tan WL, Huang WY, Yin B, Xiong J, Wu JS, Geng DY (2014) Can diffusion tensor imaging noninvasively detect IDH1 gene mutations in astrogliomas? A retrospective study of 112 cases. AJNR Am J Neuroradiol 35:920–927CrossRefPubMed
14.
Zurück zum Zitat White ML, Zhang Y, Yu F, Jaffar Kazmi SA (2011) Diffusion tensor MR imaging of cerebral gliomas: evaluating fractional anisotropy characteristics. AJNR Am J Neuroradiol 32:374–381CrossRefPubMed White ML, Zhang Y, Yu F, Jaffar Kazmi SA (2011) Diffusion tensor MR imaging of cerebral gliomas: evaluating fractional anisotropy characteristics. AJNR Am J Neuroradiol 32:374–381CrossRefPubMed
15.
Zurück zum Zitat Cha S (2006) Update on brain tumor imaging: from anatomy to physiology. AJNR Am J Neuroradiol 27:475–487PubMed Cha S (2006) Update on brain tumor imaging: from anatomy to physiology. AJNR Am J Neuroradiol 27:475–487PubMed
16.
Zurück zum Zitat Brander A, Kataja A, Saastamoinen A et al (2010) Diffusion tensor imaging of the brain in a healthy adult population: normative values and measurement reproducibility at 3T and 1.5T. Acta Radiol 51:800–807CrossRefPubMed Brander A, Kataja A, Saastamoinen A et al (2010) Diffusion tensor imaging of the brain in a healthy adult population: normative values and measurement reproducibility at 3T and 1.5T. Acta Radiol 51:800–807CrossRefPubMed
17.
Zurück zum Zitat Wang Y, Xiong J, Chu SG et al (2009) Rosette-forming glioneuronal tumor: report of an unusual case with intraventricular dissemination. Acta Neuropathol 118:813–819CrossRefPubMed Wang Y, Xiong J, Chu SG et al (2009) Rosette-forming glioneuronal tumor: report of an unusual case with intraventricular dissemination. Acta Neuropathol 118:813–819CrossRefPubMed
18.
Zurück zum Zitat Lass U, Hartmann C, Capper D et al (2013) Chromogenic in situ hybridization is a reliable alternative to fluorescence in situ hybridization for diagnostic testing of 1p and 19q loss in paraffin-embedded gliomas. Brain Pathol 23:311–318CrossRefPubMed Lass U, Hartmann C, Capper D et al (2013) Chromogenic in situ hybridization is a reliable alternative to fluorescence in situ hybridization for diagnostic testing of 1p and 19q loss in paraffin-embedded gliomas. Brain Pathol 23:311–318CrossRefPubMed
19.
Zurück zum Zitat Preusser M, Hoeftberger R, Woehrer A et al (2012) Prognostic value of Ki67 index in anaplastic oligodendroglial tumors--a translational study of the European Organization for Research and Treatment of Cancer Brain Tumor Group. Histopathology 60:885–894CrossRefPubMed Preusser M, Hoeftberger R, Woehrer A et al (2012) Prognostic value of Ki67 index in anaplastic oligodendroglial tumors--a translational study of the European Organization for Research and Treatment of Cancer Brain Tumor Group. Histopathology 60:885–894CrossRefPubMed
20.
Zurück zum Zitat Takano S, Tian W, Matsuda M et al (2011) Detection of IDH1 mutation in human gliomas: comparison of immunohistochemistry and sequencing. Brain Tumor Pathol 28:115–123CrossRefPubMed Takano S, Tian W, Matsuda M et al (2011) Detection of IDH1 mutation in human gliomas: comparison of immunohistochemistry and sequencing. Brain Tumor Pathol 28:115–123CrossRefPubMed
21.
Zurück zum Zitat Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1:307–310CrossRefPubMed Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1:307–310CrossRefPubMed
22.
Zurück zum Zitat Jenkinson MD, du Plessis DG, Smith TS, Joyce KA, Warnke PC, Walker C (2006) Histological growth patterns and genotype in oligodendroglial tumors: correlation with MRI features. Brain 129:1884–1891CrossRefPubMed Jenkinson MD, du Plessis DG, Smith TS, Joyce KA, Warnke PC, Walker C (2006) Histological growth patterns and genotype in oligodendroglial tumors: correlation with MRI features. Brain 129:1884–1891CrossRefPubMed
23.
Zurück zum Zitat Megyesi JF, Kachur E, Lee DH et al (2004) Imaging correlates of molecular signatures in oligodendrogliomas. Clin Cancer Res 10:4303–4306CrossRefPubMed Megyesi JF, Kachur E, Lee DH et al (2004) Imaging correlates of molecular signatures in oligodendrogliomas. Clin Cancer Res 10:4303–4306CrossRefPubMed
24.
Zurück zum Zitat German RB, Dehais C, Idbaih A et al (2014) Contrast enhancement in 1p/19q-codeleted anaplastic oligodendrogliomas is associated with 9p loss, genomic instability, and angiogenic gene expression. Neuro Oncol 16:662–670CrossRef German RB, Dehais C, Idbaih A et al (2014) Contrast enhancement in 1p/19q-codeleted anaplastic oligodendrogliomas is associated with 9p loss, genomic instability, and angiogenic gene expression. Neuro Oncol 16:662–670CrossRef
25.
Zurück zum Zitat Jolapara M, Patro SN, Kesavadas C et al (2011) Can diffusion tensor metrics help in preoperative grading of diffusely infiltrating astrocytomas? A retrospective study of 36 cases. Neuroradiology 53:63–68CrossRefPubMed Jolapara M, Patro SN, Kesavadas C et al (2011) Can diffusion tensor metrics help in preoperative grading of diffusely infiltrating astrocytomas? A retrospective study of 36 cases. Neuroradiology 53:63–68CrossRefPubMed
26.
Zurück zum Zitat Kitis O, Altay H, Calli C et al (2005) Minimum apparent diffusion coefficients in the evaluation of brain tumors. Eur J Radiol 55:393–400CrossRefPubMed Kitis O, Altay H, Calli C et al (2005) Minimum apparent diffusion coefficients in the evaluation of brain tumors. Eur J Radiol 55:393–400CrossRefPubMed
27.
Zurück zum Zitat Mori N, Ota H, Mugikura S, Takasawa C et al (2015) Luminal-type breast cancer: correlation of apparent diffusion coefficients with the Ki-67 labeling index. Radiology 274:66–73CrossRefPubMed Mori N, Ota H, Mugikura S, Takasawa C et al (2015) Luminal-type breast cancer: correlation of apparent diffusion coefficients with the Ki-67 labeling index. Radiology 274:66–73CrossRefPubMed
28.
Zurück zum Zitat Fudaba H, Shimomura T, Abe T et al (2014) Comparison of multiple parameters obtained on 3 T pulsed arterial spin-labeling, diffusiontensor imaging and MRS and the Ki-67 labeling index in evaluating glioma grading. AJNR Am J Neuroradiol 35:2091–2098CrossRefPubMed Fudaba H, Shimomura T, Abe T et al (2014) Comparison of multiple parameters obtained on 3 T pulsed arterial spin-labeling, diffusiontensor imaging and MRS and the Ki-67 labeling index in evaluating glioma grading. AJNR Am J Neuroradiol 35:2091–2098CrossRefPubMed
29.
Zurück zum Zitat Fischer I, Gagner JP, Law M, Newcomb EW, Zagzag D (2005) Angiogenesis in gliomas: biology and molecular pathophysiology. Brain Pathol 15:297–310CrossRefPubMed Fischer I, Gagner JP, Law M, Newcomb EW, Zagzag D (2005) Angiogenesis in gliomas: biology and molecular pathophysiology. Brain Pathol 15:297–310CrossRefPubMed
30.
Zurück zum Zitat Dogan BE, Gonzalez-Angulo AM, Gilcrease M, Dryden MJ, Yang WT (2010) Multimodality imaging of triple receptor-negative tumors with mammography, ultrasound, and MRI. AJR Am J Roentgenol 194:1160–1166CrossRefPubMed Dogan BE, Gonzalez-Angulo AM, Gilcrease M, Dryden MJ, Yang WT (2010) Multimodality imaging of triple receptor-negative tumors with mammography, ultrasound, and MRI. AJR Am J Roentgenol 194:1160–1166CrossRefPubMed
31.
Zurück zum Zitat Uematsu T, Kasami M, Yuen S (2009) Triple-negative breast cancer: correlation between MR imaging and pathologic findings. Radiology 250:638–647CrossRefPubMed Uematsu T, Kasami M, Yuen S (2009) Triple-negative breast cancer: correlation between MR imaging and pathologic findings. Radiology 250:638–647CrossRefPubMed
32.
Zurück zum Zitat Kapoor GS, Gocke TA, Chawla S et al (2009) Magnetic resonance perfusion-weighted imaging defines angiogenic subtypes of oligodendroglioma according to 1p19q and EGFR status. J Neurooncol 92:373–386CrossRefPubMed Kapoor GS, Gocke TA, Chawla S et al (2009) Magnetic resonance perfusion-weighted imaging defines angiogenic subtypes of oligodendroglioma according to 1p19q and EGFR status. J Neurooncol 92:373–386CrossRefPubMed
33.
Zurück zum Zitat Xu W, Yang H, Liu Y et al (2011) Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of a-ketoglutarate-dependent dioxygenases. Cancer Cell 19:17–30CrossRefPubMedPubMedCentral Xu W, Yang H, Liu Y et al (2011) Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of a-ketoglutarate-dependent dioxygenases. Cancer Cell 19:17–30CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Olar A, Raghunathan A, Albarracin CT et al (2012) Absence of IDH1-R132H mutation predicts rapid progression of nonenhancing diffuse glioma in older adults. Ann Diagn Pathol 16:161–170CrossRefPubMed Olar A, Raghunathan A, Albarracin CT et al (2012) Absence of IDH1-R132H mutation predicts rapid progression of nonenhancing diffuse glioma in older adults. Ann Diagn Pathol 16:161–170CrossRefPubMed
35.
Zurück zum Zitat Wang S, Kim S, Chawla S et al (2009) Differentiation between glioblastomas and solitary brain metastases using diffusion tensor imaging. Neuroimage 44:653–660CrossRefPubMedPubMedCentral Wang S, Kim S, Chawla S et al (2009) Differentiation between glioblastomas and solitary brain metastases using diffusion tensor imaging. Neuroimage 44:653–660CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Beppu T, Inoue T, Shibata Y et al (2005) Fractional anisotropy value by diffusion tensor magnetic resonance imaging as a predictor of cell density and proliferation activity of glioblastomas. Surg Neurol 63:56–61CrossRefPubMed Beppu T, Inoue T, Shibata Y et al (2005) Fractional anisotropy value by diffusion tensor magnetic resonance imaging as a predictor of cell density and proliferation activity of glioblastomas. Surg Neurol 63:56–61CrossRefPubMed
37.
Zurück zum Zitat Louis DN, Perry A, Burger P et al (2014) International Society Of Neuropathology-Haarlem consensus guidelines for nervous system tumor classification and grading. Brain Pathol 24:429–435CrossRefPubMed Louis DN, Perry A, Burger P et al (2014) International Society Of Neuropathology-Haarlem consensus guidelines for nervous system tumor classification and grading. Brain Pathol 24:429–435CrossRefPubMed
Metadaten
Titel
Combination of diffusion tensor imaging and conventional MRI correlates with isocitrate dehydrogenase 1/2 mutations but not 1p/19q genotyping in oligodendroglial tumours
verfasst von
Ji Xiong
Wenli Tan
Jianbo Wen
Jiawei Pan
Yin Wang
Jun Zhang
Daoying Geng
Publikationsdatum
22.09.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 6/2016
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-015-4025-4

Weitere Artikel der Ausgabe 6/2016

European Radiology 6/2016 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.